Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD .
Filed returns
118
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | MSD | Health | Oncology nursing workforce and cancer care service policy (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2026 | MSD | Health | Pulmonary Arterial Hypertension (PAH) services (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2026 | MSD | Health | To provide an overview of MSD's operations in Co. Meath and discuss health and industry policy issues (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | MSD | Health | Discussion on EU pharmaceutical policy during Irish EU Presidency (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | National Cancer Strategy & future of cancer care in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Life Science Strategy Public Consultation (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Engagement on Life Sciences and Innovation Policy (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Cancer dashboard Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | EU Safe Hearts Plan (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Cancer Outcomes in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | EU Cardiovascular Diseases Strategy (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Health and Innovation Policy (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Health Policy (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | MSD | Health | Health Policy Awareness (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | MSD | Health | Rare disease strategy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | MSD | Health | Health and industry policy (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | pulmonary arterial hypertension (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Implementing an Early Access Scheme in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | HPV catch-up vaccination programme (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Strategic Operations in Ireland & Healthcare Priorities for MSD Biotech (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Health and industry policy (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Advocacy on Pulmonary Arterial Hypertension Policy in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Ireland’s Cervical Cancer Elimination Plan (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Healthcare Innovation (Public policy or programme) | 8 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | One Substance, One Assessment' (OSOA) chemical assessment EU reform (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | New Medicines Funding (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Reform of the EU pharmaceutical legislation (Legislation) | 7 | On lobbying.ie |
| Sep–Dec 2024 | MSD | Health | Urban Waste Water Treatment Directive (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2024 | MSD | Health | Health Policy Development for New Programme for Government (Public policy or programme) | 46 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | Meeting to discuss health policy matters with the opposition health spokesperson. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | To highlight to the new Minister of Finance MSD Ireland finance related health policy matters. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | Meeting with officials from the Department of Health as part of a delegation from the US Chamber of Commerce, to discuss industry wide concerns in Ireland regarding the impact of some aspects of the EU Commission’s… (Legislation) | 1 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | European policy on innovative pharmaceutical medicine (Public policy or programme) | 19 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | Meeting to discuss rare disease health policy development in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | EU Regulatory Data Protection Policy and Reimbursement Policy (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | pediatric hospitalisations in Ireland due to Varicella in 2023 (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | The improvement of the reimbursement process (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | Access Policy for innovative medicines and rare diseases in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | The importance of predictability in IP rights in the EU Pharmaceutical Legislation revision (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | Meetings to highlight the importance of predictability in IP rights in EU Pharmaceutical Legislation revision (Legislation) | 5 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | Meeting to discuss pharma industry in Ireland and importance of (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Early detection and treatment of cancer (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Access to Innovative Medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Access to Innovative Medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Continued importance of a competitive and favorable business environment in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | National Immunisation programme (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | To highlight problems in Ireland faced by patients with TNBC and policy areas that need focus. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 118 | 100.0% |